Unimed Pharmaceuticals begins HIV wasting syndrome trial.
D000163:Acquired Immunodeficiency Syndrome / Q000097:blood / Q000150:complications*; D000287:Administration, Topical; D002100:Cachexia / Q000150:complications / Q000188:drug therapy*; D013196:Dihydrotestosterone / Q000008:administration & dosage / Q000627:therapeutic use*; D005782:Gels; D006801:Humans; D013739:Testosterone / Q000097:blood; D015431:Weight Loss
D005782:Gels; D013196:Dihydrotestosterone; D013739:Testosterone